Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation

Imad Libbus; Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro; Badri Amurthur; Bruce H KenKnight; Lorenzo A DiCarlo; Inder S Anand

doi:10.3389/fphys.2022.853617

Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation

Front Physiol. 2022 Mar 11:13:853617. doi: 10.3389/fphys.2022.853617. eCollection 2022.

Authors

Imad Libbus¹, Rajendra K Premchand², Kamal Sharma³, Sanjay Mittal⁴, Rufino Monteiro⁵, Badri Amurthur¹, Bruce H KenKnight¹, Lorenzo A DiCarlo¹, Inder S Anand⁶

Affiliations

¹ LivaNova USA, Inc., Houston, TX, United States.
² Krishna Institute of Medical Sciences, Secunderabad, India.
³ Sanjivani Super Specialty Hospitals, Ahmedabad, India.
⁴ Medanta, The Medicity, Haryana, India.
⁵ Vintage Hospital, Panaji, India.
⁶ Emeritus, University of Minnesota, Minneapolis, MN, United States.

Abstract

Introduction: Although heart failure (HF) outcomes have improved dramatically with the use of guideline directed medical therapy and implantable devices, the overall prognosis of patients with HF and reduced ejection fraction (HFrEF) remains poor. Autonomic Regulation Therapy (ART) using chronic vagus nerve stimulation (VNS) has been evaluated in the ANTHEM-HF study, using changes in heart rate (HR) dynamics as a biomarker of autonomic nervous system engagement and cardiac control to guide VNS titration. ART was associated with sustained improvement in cardiac function and HF symptoms in patients with HFrEF and persistent HF symptoms despite guideline-directed medical therapy (GDMT). We sought to determine whether the responsiveness of the autonomic nervous system to ART, as reflected in HR response to vagus stimulation during the VNS duty cycle, is maintained after long-term chronic VNS administration.

Methods: Fifteen patients with HFrEF and implanted with a VNS systems in the ANTHEM-HF study were evaluated after 4.7 ± 0.3 years (range: 4.0-5.0 years) of chronic ART. ECG electrodes were placed on each patient's wrists, and ECG rhythm strips were recorded. Instantaneous HR time series was computed at each patient's chronically programmed VNS intensity and during progressively increasing VNS intensity. HR during active stimulation (on-time) was compared to HR just prior to initiation of each stimulation cycle (off-time).

Results: Persistent autonomic engagement was observed in a majority of patients (11 of 15, 73%) after chronic ART for four or more years. The average magnitude of HR reduction during ART on-time in all patients was 2.4 ± 3.2 bpm at the chronically programmed VNS pulse parameter settings.

Conclusion: Autonomic responsiveness to VNS persists in patients with HFrEF who received chronic ART for up to 5 years as a supplement to GDMT. This suggests that the effects of ART on autonomic engagement and cardiac control remain durable over time.

Clinical trial registration: [ClinicalTrials.gov], identifier [#NCT01823887, CTRI registration #CTRI/2012/05/002681].

Keywords: autonomic regulation therapy; guideline directed medical therapy; heart failure; non-pharmacological therapy; vagus nerve stimulation.

Associated data

ClinicalTrials.gov/NCT01823887